Hannah Daniel is a journalist whose work has appeared in Informa. She covers a wide range of topics, including medical technology, healthcare regulations, and industry updates. Hannah's articles provide valuable insights and updates on the latest developments in the field, keeping readers informed and engaged.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Hannah's reporting focuses on healthcare and medical technology, with a strong emphasis on government announcements and industry updates. Her coverage also includes significant attention to FDA regulations, data breaches in the healthcare industry, and the integration of artificial intelligence in healthcare.
Given her focus on government announcements and press releases related to medical technology and FDA regulations, Hannah may be particularly interested in pitches that offer expert insights into new guidelines or policies within these areas. She is likely seeking sources who can provide informed perspectives on how recent developments will impact the healthcare industry.
It's worth noting that Hannah does not appear to have a specific geographic focus but covers topics relevant to the broader healthcare industry without geographical constraints.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Hannah Daniel
The long-awaited TCET final notice doesn't address major concerns, medtech industry advocates say.
By: Hannah Daniel
DHAC's members, which span across multiple disciplines in the digital health industry, will hold their inaugural meeting this November.
By: Brian Bossetta, Hannah Daniel, Marion Webb
This week, Medtronic recalled a nerve monitoring system due to reports of false responses. The US FDA approved the first auto-injector for opioid-overdose, made by Purdue Pharma. The agency granted de novo authorization for Labcorp's PGDx elio plasma focus Dx used by labs for genetic profiling. As of 7 August, 950 AI/ML devices have been approved by the FDA. EKO Health teamed up with LSU to help detect arrhythmias and murmurs in student-athletes.
By: Hannah Daniel
Avenda's chief operating officer Brit Berry-Pusey spoke to Medtech Insight about the company's CPT III code for its prostate cancer mapping AI and how regulatory bodies can align to support innovators.
By: Hannah Daniel
Despite a March recall and a following update, Tandem's t:slim X2 application is still causing the battery-depleting defect.
By: Hannah Daniel
The FDA designated class II special controls classifications for two diagnostics and force separation catheters.
By: Hannah Daniel
Biosensors are a fundamental tool in research and have promising future applications in health care.
2024 Physics Nobel Prize Resources from AIP
Although quieter, continuous active sonar still interferes too much with killer whale communication.
The inexpensive toy can be used as a macro model for complex physical principles. DOI:
(833) 317-6278 
